Edmond De Rothschild Holding S.A. Kamada LTD Transaction History

Edmond De Rothschild Holding S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$4.68 - $6.25 $94,536 - $126,250	-20,200 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$5.15 - $6.3 $113,300 - $138,600	-22,000 Reduced 52.13%	20,200 $125,000
Q3 2017 Nov 13, 2017	BUY	$4.25 - $4.8 $179,350 - $202,560	42,200	42,200 $204,000

5.67M

300

151K

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $254M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.